Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,120.00
+10.00 (0.14%)
At close: Apr 29, 2026
2.45%
Market Cap 99.79B
Revenue (ttm) 202.40B
Net Income (ttm) 15.26B
Shares Out 14.04M
EPS (ttm) n/a
PE Ratio 6.54
Forward PE n/a
Dividend 100.00 (1.41%)
Ex-Dividend Date Dec 29, 2025
Volume 28,480
Average Volume 82,517
Open 7,180.00
Previous Close 7,110.00
Day's Range 7,080.00 - 7,180.00
52-Week Range 6,300.00 - 8,810.00
Beta 0.27
RSI 48.47
Earnings Date Dec 2, 2025

About Daehan Nupharm

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The compa... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 228
Stock Exchange KOSDAQ
Ticker Symbol 054670
Full Company Profile

Financial Performance

In 2025, Daehan Nupharm's revenue was 202.40 billion, an increase of 0.11% compared to the previous year's 202.19 billion. Earnings were 15.26 billion, a decrease of -1.36%.

Financial Statements

News

There is no news available yet.